Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 MRI Database 
SEARCH FOR    
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
previous     56 - 60 (of 113)     next 
C--Ca   Ca-Ca   Ca-Ca   Ca-Ce   Ce-Ch   Ch-Ch   Ch-Ci   Ci-Cl   Cl-Cl   Cl-Co   Co-Co   Co-Co     Co-Co   Co-Co   Co-Co   Co-Co   Co-Co   Co-Co   Co-Co   Co-Cr   Cr-Cr   Cr-Cr   Cr-Cy   
MRI Resources 
Contrast Agents - MRI Technician and Technologist Career - Examinations - Libraries - Contrast Enhanced MRI - Research Labs
 
Coil LoadingInfoSheet: - Coils -
Intro, 
Overview, 
etc.
 
The interaction of the patient with the RF coil, which causes shifts of the resonance frequency and damping of the coil's resonance and hence reduction of the quality factor because of magnetic induction and dielectric losses in the patient.
The design and construction of a MRI coil is determined by the load on the coil. The load is either a phantom or the actual sample being imaged.

See also Radio Frequency Coil.
spacer

• View the DATABASE results for 'Coil Loading' (2).Open this link in a new window

Combidex®InfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Combidex® is the brand name (same as Sinerem®) for an ultrasmall superparamagnetic iron oxide (USPIO) in the development pipeline to detect metastatic disease in lymph nodes. Metastatic lymph nodes show less uptake of this MRI contrast agent, which results in less signal decrease and allows the differentiation of normal lymph nodes from normal-sized, metastatic nodes. Combidex® has also potential to be used as a functional molecular imaging agent.
In March 2005, AMAG Pharmaceuticals Inc received an approvable letter from the U.S. Food and Drug Administration with respect to Combidex subject to certain conditions.
See also Ferumoxtran, Drug Development and Approval Process USA, Molecular Imaging and Classifications, Characteristics, etc.
Drug Information and Specification
NAME OF COMPOUND
Ferumoxtran, USPIO, AMI-227
CENTRAL MOIETY
Fe3+/Fe2+
CONTRAST EFFECT
T1, predominantly T2
r1=25, r2=160, B0=0.47T, r1=23.3, r2=48.9, B0=0.47T
PHARMACOKINETIC
Vascular, lymph v. hepatocyte (AG-USPIO)
DOSAGE
2.6 mg Fe/kg
PREPARATION
Suspend in an isotonic glucose solution
INDICATION
Lymph node, (MR angiography vascular, staging of RES-directed liver diseases)
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
spacer

• View the NEWS results for 'Combidex®' (1).Open this link in a new window.

• View the DATABASE results for 'Combidex®' (6).Open this link in a new window

 
Further Reading:
  Basics:
The demise of Combidex - Sinerem
Wednesday, 24 March 2010   by www.wellsphere.com    
  News & More:
Combidex, MRI, and identification of nodal metastases
Wednesday, 17 June 2009   by prostatecancerinfolink.net    
Superparamagnetic Iron Oxide–enhanced MR Imaging of Head and Neck Lymph Nodes1
MRI Resources 
Pregnancy - Implant and Prosthesis pool - Portals - - Cochlear Implant - Software
 
Combination Oral Contrast AgentsInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Biphasic oral contrast agents may produce either high or low signal intensities depending on the pulse sequence used, for example low signal intensity on T1 weighted MR images and high signal intensity on T2 weighted images. The combination of different oral contrast agents can generate a macroscopic cancellation of negative and positive magnetic susceptibility, thereby eliminating susceptibility artifacts.
Possible combinations are e.g., ferric ammonium citrate and corn oil, or ferrous sulfate emulsified with baby formula. Paramagnetic agents combined with oil emulsion may be used in MRI as positive abdominal contrast agents. The combination of diamagnetic barium sulfate and superparamagnetic iron oxide (SPIO) in one suspension may be a useful negative contrast agent.

See also Gastrointestinal Paramagnetic Contrast Agents, Gastrointestinal Superparamagnetic Contrast Agents, Gastrointestinal Diamagnetic Contrast Agents, Gastrointestinal Imaging.
spacer

• View the DATABASE results for 'Combination Oral Contrast Agents' (3).Open this link in a new window

 
Further Reading:
  Basics:
Usefulness of MR Imaging for Diseases of the Small Intestine: Comparison with CT
2000   by www.ncbi.nlm.nih.gov    
Completely Balanced Steady StateInfoSheet: - Sequences -
Intro, Overview, 
Types of, 
etc.MRI Resource Directory:
 - Sequences -
 
(CBASS) A gradient echo sequence with balanced waveform.

See Steady State Free Precession and Balanced Sequence.
spacer

• View the DATABASE results for 'Completely Balanced Steady State' (2).Open this link in a new window

Complex Conjugate
 
An operation on a complex number, which negates the sign of the imaginary component of a complex vector. The two vectors then form a complex-conjugate pair.
spacer

• View the DATABASE results for 'Complex Conjugate' (6).Open this link in a new window

 
Further Reading:
  Basics:
Complex Number
   by en.wikipedia.org    
MRI Resources 
Artifacts - MRCP - Directories - Safety Training - Services and Supplies - Sequences
 
previous       56 - 60 (of 113)      next 
C--Ca   Ca-Ca   Ca-Ca   Ca-Ce   Ce-Ch   Ch-Ch   Ch-Ci   Ci-Cl   Cl-Cl   Cl-Co   Co-Co    Co-Co    Co-Co   Co-Co   Co-Co   Co-Co   Co-Co   Co-Co   Co-Co   Co-Cr   Cr-Cr   Cr-Cr   Cr-Cy   
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Next big thing in MRI will be :
AI 
remote operator 
personalized protocols 
helium-free 
molecular MRI 
portable MRI 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 28 September 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]